INCOG BioPharma Services

INCOG BioPharma Services

Private
Fishers, IndianaHealthcare & Life Scienceshttps://incogbiopharma.com

Last Round

Grant

Dec 16, 2025

Total Funding Raised

$57.86M

Momentum Score

50 /100

Company Overview

INCOG BioPharma Services is a contract development and manufacturing organization (CDMO) that provides end-to-end services for sterile injectable drug products for the global biopharmaceutical market. Founded in 2020, the company supports biopharmaceutical partners from clinical through commercial stages. Its services include injectable drug product formulation, analytical method development, process scale-up, and the filling of vials, syringes, and cartridges. INCOG also offers customized packaging, device assembly, and integrated storage solutions. The company operates out of an FDA-approved, 90,000 sq. ft. facility in Fishers, Indiana, and is actively expanding its capacity to meet growing market demand.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Clinical Trials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationsterile injectablesfill-finishpharmaceutical contract manufacturingaseptic fill-finishdrug product manufacturingdevice assemblyformulation developmentbiopharmaceutical servicescommercial scale manufacturingclinical trial manufacturingquality control testingautoinjector assemblyvial fillingsyringe fillingserialization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

INCOG BioPharma Services Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

INCOG BioPharma Services Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2025
Series CMay 29, 2024
DebtMay 10, 2022
Series BApr 26, 2022

Key People

Founding team and executive leadership

Tedd Green

Co-founder Chief Operating Officer

Founding Team

Cory Lewis

CEO And President, Founder, Board Member

Founding Team

Doug Dayhoff

CFO

Executive Team

INCOG BioPharma Services Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 16, 2025

    Secured $13.1M in grant funding.

  • Mar 18, 2025

    Expanding into manufacturing for drug and medical device combination products.

INCOG BioPharma Services Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

INCOG BioPharma Services Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about INCOG BioPharma Services's valuation, stock price, and market status.

Firmographic Details

HeadquartersFishers, Indiana
Employee Range304
Year Founded2020
Last FundingDec 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.